"Receptors, Purinergic P1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of cell surface receptors that prefer ADENOSINE to other endogenous PURINES. Purinergic P1 receptors are widespread in the body including the cardiovascular, respiratory, immune, and nervous systems. There are at least two pharmacologically distinguishable types (A1 and A2, or Ri and Ra).
| Descriptor ID |
D018047
|
| MeSH Number(s) |
D12.776.543.750.695.700.700 D12.776.543.750.720.700.700
|
| Concept/Terms |
Receptors, Purinergic P1- Receptors, Purinergic P1
- Adenosine Receptors
- Receptors, Adenosine
- P1 Purinoceptors
- Purinoceptors, P1
- Receptor, Purinergic P1
- P1 Receptor, Purinergic
- Purinergic P1 Receptor
- Purinergic P1 Receptors
- P1 Receptors, Purinergic
- Adenosine Receptor
- Receptor, Adenosine
- P1 Purinoceptor
- Purinoceptor, P1
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Purinergic P1".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Purinergic P1".
This graph shows the total number of publications written about "Receptors, Purinergic P1" by people in this website by year, and whether "Receptors, Purinergic P1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 2 | 3 |
| 2001 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Purinergic P1" by people in Profiles.
-
Sakkal LA, Rajkowski KZ, Armen RS. Prediction of consensus binding mode geometries for related chemical series of positive allosteric modulators of adenosine and muscarinic acetylcholine receptors. J Comput Chem. 2017 06 05; 38(15):1209-1228.
-
Anderson WD, Makadia HK, Vadigepalli R. Molecular variability elicits a tunable switch with discrete neuromodulatory response phenotypes. J Comput Neurosci. 2016 Feb; 40(1):65-82.
-
Feldman AM, Cheksis-Feiner E, Hamad E, Chan T. Adenosine receptor subtypes and the heart failure phenotype: translating lessons from mice to man. Trans Am Clin Climatol Assoc. 2011; 122:198-214.
-
Mundell SJ, Matharu AL, Nisar S, Palmer TM, Benovic JL, Kelly E. Deletion of the distal COOH-terminus of the A2B adenosine receptor switches internalization to an arrestin- and clathrin-independent pathway and inhibits recycling. Br J Pharmacol. 2010 Feb 01; 159(3):518-33.
-
Penn RB, Pascual RM, Kim YM, Mundell SJ, Krymskaya VP, Panettieri RA, Benovic JL. Arrestin specificity for G protein-coupled receptors in human airway smooth muscle. J Biol Chem. 2001 Aug 31; 276(35):32648-56.
-
Matharu AL, Mundell SJ, Benovic JL, Kelly E. Rapid agonist-induced desensitization and internalization of the A(2B) adenosine receptor is mediated by a serine residue close to the COOH terminus. J Biol Chem. 2001 Aug 10; 276(32):30199-207.
-
Mundell SJ, Matharu AL, Kelly E, Benovic JL. Arrestin isoforms dictate differential kinetics of A2B adenosine receptor trafficking. Biochemistry. 2000 Oct 24; 39(42):12828-36.
-
Santini F, Penn RB, Gagnon AW, Benovic JL, Keen JH. Selective recruitment of arrestin-3 to clathrin coated pits upon stimulation of G protein-coupled receptors. J Cell Sci. 2000 Jul; 113 ( Pt 13):2463-70.
-
Gottlieb SS, Skettino SL, Wolff A, Beckman E, Fisher ML, Freudenberger R, Gladwell T, Marshall J, Cines M, Bennett D, Liittschwager EB. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. J Am Coll Cardiol. 2000 Jan; 35(1):56-9.
-
Willets JM, Parent JL, Benovic JL, Kelly E. Selective reduction in A2 adenosine receptor desensitization following antisense-induced suppression of G protein-coupled receptor kinase 2 expression. J Neurochem. 1999 Nov; 73(5):1781-9.